News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Continues to Throw Cold Water on Amarin Corporation PLC (AMRN)'s Hopes for Vascepa


10/30/2013 7:29:00 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Any remaining hopes for an expanded indication for Amarin’s Vascepa were largely dashed today by the FDA. Although it hasn’t yet rejected the proposed indication, the FDA today essentially overturned the foundation of the application, leaving little doubt as to the ultimate fate of the proposed new indication.

Help employers find you! Check out all the jobs and post your resume.

Read at Forbes
Read at Business Week
Read at Seeking Alpha
Read at Wall Street Journal


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES